Envestnet Portfolio Solutions, Inc. Intra Cellular Therapies, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $28 Billion
- Q3 2024
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 4,888 shares of ITCI stock, worth $423,887. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,888
Previous 4,117
18.73%
Holding current value
$423,887
Previous $281,000
27.05%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ITCI
# of Institutions
378Shares Held
84.7MCall Options Held
319KPut Options Held
143K-
Vanguard Group Inc Valley Forge, PA9.63MShares$835 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$548 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$458 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.85MShares$334 Million1.4% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.05MShares$264 Million3.36% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.19B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...